CN1076200A - 新型β-氨基酸衍生物 - Google Patents

新型β-氨基酸衍生物 Download PDF

Info

Publication number
CN1076200A
CN1076200A CN93102483A CN93102483A CN1076200A CN 1076200 A CN1076200 A CN 1076200A CN 93102483 A CN93102483 A CN 93102483A CN 93102483 A CN93102483 A CN 93102483A CN 1076200 A CN1076200 A CN 1076200A
Authority
CN
China
Prior art keywords
group
formula
acid
amino
chemical formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN93102483A
Other languages
English (en)
Chinese (zh)
Inventor
G·科蒂尔什
R·梅特尼希
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of CN1076200A publication Critical patent/CN1076200A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Materials For Medical Uses (AREA)
CN93102483A 1992-03-10 1993-03-09 新型β-氨基酸衍生物 Pending CN1076200A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4207544.0 1992-03-10
DE4207544 1992-03-10

Publications (1)

Publication Number Publication Date
CN1076200A true CN1076200A (zh) 1993-09-15

Family

ID=6453662

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93102483A Pending CN1076200A (zh) 1992-03-10 1993-03-09 新型β-氨基酸衍生物

Country Status (26)

Country Link
US (1) US5561112A (enExample)
EP (1) EP0560730B1 (enExample)
JP (1) JP2860222B2 (enExample)
KR (1) KR930019690A (enExample)
CN (1) CN1076200A (enExample)
AT (1) ATE142618T1 (enExample)
AU (1) AU659281B2 (enExample)
CA (1) CA2091292A1 (enExample)
CZ (1) CZ36193A3 (enExample)
DE (1) DE69304573T2 (enExample)
DK (1) DK0560730T3 (enExample)
ES (1) ES2090934T3 (enExample)
FI (1) FI931023A7 (enExample)
GR (1) GR3021030T3 (enExample)
HU (2) HUT63609A (enExample)
IL (1) IL104972A (enExample)
MX (1) MX9301298A (enExample)
MY (1) MY109060A (enExample)
NO (1) NO300778B1 (enExample)
NZ (1) NZ247084A (enExample)
PH (1) PH30893A (enExample)
RU (1) RU2106356C1 (enExample)
SG (1) SG47059A1 (enExample)
SK (1) SK17093A3 (enExample)
TW (1) TW256828B (enExample)
ZA (1) ZA931724B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
GB9406144D0 (en) * 1993-03-29 1994-05-18 Zeneca Ltd Heterocyclic compounds
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
NZ262941A (en) * 1993-03-29 1997-07-27 Zeneca Ltd Pyridine derivatives and medicaments
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
US5811398A (en) * 1995-04-11 1998-09-22 G. D. Searle & Co. Platelet aggregation inhibitors containing C-terminal aminergic side chain amino acid residues
EP0892780B1 (en) * 1996-02-22 2002-11-20 Bristol-Myers Squibb Pharma Company M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
US5942544A (en) * 1996-02-22 1999-08-24 Dupont Pharmaceuticals Company α-branched anilines, toluenes, and analogs thereof as factor Xa inhibitors
UA63887C2 (en) * 1996-10-28 2004-02-16 Lg Chemical Ltd Selective thrombin inhibitors and a pharmaceutical composition based thereon
WO2003063910A2 (en) * 2002-01-28 2003-08-07 Novartis Ag β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
NL8820210A (nl) * 1987-04-08 1989-03-01 Nippon Shinyaku Co Ltd Nootropisch middel.
IT1222437B (it) * 1987-08-04 1990-09-05 Ellem Ind Farmaceutica Tripeptidi utili come immunostimolanti e nella prevenzione delle metastasi e relativo procedimento di preparazione
US5037808A (en) * 1988-07-20 1991-08-06 Monsanto Co. Indolyl platelet-aggregation inhibitors
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
US5273982A (en) * 1990-03-09 1993-12-28 Hoffmann-La Roche Inc. Acetic acid derivatives
CA2037153A1 (en) * 1990-03-09 1991-09-10 Leo Alig Acetic acid derivatives
US5354738A (en) * 1992-09-04 1994-10-11 G. D. Searle & Co. Platelet aggregation inhibitors

Also Published As

Publication number Publication date
FI931023A0 (fi) 1993-03-08
CA2091292A1 (en) 1993-09-11
CZ36193A3 (en) 1994-01-19
NO300778B1 (no) 1997-07-21
SG47059A1 (en) 1998-03-20
DE69304573D1 (de) 1996-10-17
EP0560730B1 (en) 1996-09-11
IL104972A (en) 1998-04-05
EP0560730A3 (en) 1993-12-01
PH30893A (en) 1997-12-23
IL104972A0 (en) 1993-07-08
AU3406993A (en) 1993-09-16
NO930830D0 (no) 1993-03-08
AU659281B2 (en) 1995-05-11
HUT63609A (en) 1993-09-28
HU9300501D0 (en) 1993-05-28
KR930019690A (ko) 1993-10-18
GR3021030T3 (en) 1996-12-31
HU210878A9 (en) 1995-09-28
MY109060A (en) 1996-11-30
NO930830L (no) 1993-09-13
ES2090934T3 (es) 1996-10-16
EP0560730A2 (en) 1993-09-15
ATE142618T1 (de) 1996-09-15
FI931023L (fi) 1993-09-11
FI931023A7 (fi) 1993-09-11
SK17093A3 (en) 1993-10-06
NZ247084A (en) 1995-09-26
TW256828B (enExample) 1995-09-11
DK0560730T3 (da) 1996-10-28
DE69304573T2 (de) 1997-03-20
JPH0665175A (ja) 1994-03-08
MX9301298A (es) 1993-10-01
JP2860222B2 (ja) 1999-02-24
RU2106356C1 (ru) 1998-03-10
ZA931724B (en) 1994-09-10
US5561112A (en) 1996-10-01

Similar Documents

Publication Publication Date Title
CN1099425C (zh) 新的肽衍生物
CN1079792C (zh) 酶抑制剂
US6872805B2 (en) Hepatitis C virus inhibitors
EP1268525B1 (en) Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
CN1076200A (zh) 新型β-氨基酸衍生物
KR100254757B1 (ko) N-아실-알파-아미노산 유도체
IE902815A1 (en) Renin inhibitors, processes for their preparation and their¹use in medicaments
CN1346365A (zh) 可有效对抗c型肝炎病毒的巨环肽
MXPA06003455A (es) Inhibidores macrociclicos de la serina proteasa ns3 del virus de la hepatitis c.
AU2002248147A1 (en) Hepatitis C tripeptide inhibitors
CN1074438A (zh) 抗血栓剂
SG180022A1 (en) Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
TW201446807A (zh) 三肽環氧酮蛋白酶體抑制劑
CN1068112A (zh) 具有血管紧张肽原酶抑制性能的化合物，及其制备方法和使用
CN1231659A (zh) N[n－n－(4－哌啶－4－基)丁酰基)－n－乙基甘氨酰基]化合物的不吸湿的稳定结晶形式
CN1304415C (zh) 作为ace和nep抑制剂的吡喃衍生物
JPH0892227A (ja) 接着レセプター拮抗薬
CN1149877A (zh) 新型弹性蛋白酶抑制剂
CN1231671A (zh) 抗血栓形成的氮杂环烷基链烷酰基肽和假肽
JP4047365B2 (ja) シクロアルカンカルボキサミド誘導体及びその製造方法
JP4616833B2 (ja) Ｎ−〔（ｓ）−１−カルボキシブチル〕−（ｓ）−アラニンのエステルの、新規な合成方法およびペリンドプリルの合成における使用
JP6336973B2 (ja) α−オキソアシルアミノカプロラクタム誘導体
Jakubec et al. Crystallisation-induced asymmetric transformation (CIAT) for the synthesis of dipeptides containing homophenylalanine
EP1826199A1 (en) Modified amino acids
JP4008019B1 (ja) シクロアルキルカルボニルアミノ酸エステル誘導体及びその製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned